Stock

Inhibrx Biosciences, Inc. INBX

$92.41-0.66%

All stocks Create account to unlock

Overview

INBX market data

Price History

INBX price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for INBX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

7 captured

8-K filing — Inhibrx Biosciences, Inc. (INBX) · Jul 16, 2026, 8:06 PM

Inhibrx Biosciences Says FDA Accepts BLA Seeking Approval Of Ozekibart In Patients With Conventional Chondrosarcoma; PDUFA Goal Date Set For April 14, 2027 · Jun 15, 2026, 1:25 PM

Inhibrx Biosciences shares are trading lower after the company reported worse-than-expected Q1 EPS results. · May 15, 2026, 3:53 PM

Inhibrx Reports First Quarter 2026 Financial Results · May 14, 2026, 9:15 PM

Inhibrx Biosciences Q1 EPS $(2.15) Misses $(1.79) Estimate · May 14, 2026, 8:38 PM

Inhibrx Biosciences shares are trading higher after the company announced interim results from the randomized, first-line Phase 2 portion of the HexAgon study. · May 11, 2026, 12:41 PM

Inhibrx Reports Interim Phase 2 Data For INBRX-106 In First-Line HNSCC · May 11, 2026, 12:10 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock